Advances in the cell biology and genetics of human kidney malformations

Journal of the American Society of Nephrology

Volumn 9, Issue 6, 1998, Pages 1114-1125

  Woolf, Adrian S ^a,b   Winyard, Paul J D ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CELL ADHESION MOLECULE; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; GALECTIN 3; GLUCOSE; GONADORELIN; GROWTH FACTOR; RECEPTOR; RETINOIC ACID; RETINOL; TERATOGENIC AGENT; THALIDOMIDE; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL PROLIFERATION; CYTOLOGY; GENE; GENE EXPRESSION; GENE MUTATION; HUMAN; IN SITU HYBRIDIZATION; KALLMANN SYNDROME; KIDNEY MALFORMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNDROME;

EID: 0031749132     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (150)

1. Bard JBH, Woolf AS: Nephrogenesis and the development of renal disease. Nephrol Dial Transplant 7: 563-572, 1992
2. Risdon RA, Woolf AS: Development of the kidney. In: Heptinstall's Pathology of the Kidney, 5th Ed., Chapter 2, edited by Jennette JC, Olson JL, Schwartz MM, Silva FG, New York, Lippincott-Raven, 1998, pp 67-84, in press
3. Woolf AS: The biology of kidney malformations. In: Embryos, Genes and Birth Defects, edited by Thorogood P, John Wiley and Sons, 1997, pp 303-327
4. Bernstein J, Risdon RA, Gilbert-Barness E: Renal system. In: Potter's Pathology of the Fetus and Infant, 4th Ed., edited by Gilbert-Barness E, St. Louis, Mosby, 1997, pp 863-935
5. Potter EL: Normal and Abnormal Development of the Kidney, Chicago, Year Book Medical Publishers, 1972
6. Nomura S, Osawa G: Focal glomerular sclerotic lesions in a patient with oligomeganephronia and agenesis of the contralateral kidney. Clin Nephrol 33: 7-11, 1990
7. Genest DR, Lage JM: Absence of normal-appearing proximal tubules in the fetal and neonatal kidney: Prevalence and significance. Hum Pathol 22: 147-153, 1991
8. Zerres K, Mucher G, Bachner L, Deschennes G, Eggerman T, Kaariainen H, Knapp M, Lennert T, Misselwitz J, von Munlendahl KE, Neumann HPH, Pirson Y, Rudnik-Schoneborn S, Steinbicker V, Wirth B, Scharer K: Mapping of the gene for autosomal recessive polycystic kidney disease to chromosome 6p21-cen. Nat Genet 7: 429-432, 1994
9. Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM, Nellist M, Gamble V, Harris PC, Sampson JR: Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease: A contiguous gene syndrome. Nat Genet 8: 328-332, 1994
10. Feather S, Woolf AS, Malcolm S, Donnai D, Winter R: The oral-facial-digital syndrome type 1, a cause of polycystic kidney disease and associated malformations, maps to Xp22.2-22.3. Hum Mol Genet 7: 1163-1167, 1997
11. McKusick VA: Mendelian Inheritance in Man, 10th Ed., Baltimore, John Hopkins University Press, 1992
12. Woolf AS: The single kidney. In: Pediatric Surgery and Urology: Long-Term Outcomes, Chapter 50, London, W. B. Saunders, 1998, pp 625-631
13. McEnery PT, Stablein DM, Arbus G, Tejani A: Renal transplantation in children. N Engl J Med 326: 1727-1732, 1992
14. Ehrich JHH, Rizzoni G, Brunner FP, Fassbinder W, Geerlings W, Mallick NP, Raine AEG, Selwood NH, Tufveson G: Renal replacement therapy for end-stage renal failure before 2 years of age. Nephrol Dial Transplant 7: 1171-1177, 1992
15. Carter CO, Evans K, Pescia G: A familial study of renal agenesis. J Med Genet 16: 176-188, 1979
16. Potter EL: Bilateral renal agenesis. J Pediatr 29: 68-76, 1946
17. Roodhooft AM, Birnholz JC, Holmes LB: Familial nature of congenital absence and severe dysgenesis of both kidneys. N Engl J Med 310: 1341-1345, 1984
18. Kiprov DD, Calvin RB, McLuskey RT: Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis. Lab Invest 46: 275-281, 1982
19. Atiyeh B, Husmann D, Baum M: Contralateral renal abnormalities in patients with renal agenesis and noncystic renal dysplasia. Pediatrics 91: 812-815, 1993
20. Greene LF, Feinzaig W, Dahlin DC: Multicystic dysplasia of the kidney with special reference to the contralateral kidney. J Urol 105: 482-488, 1971
21. Thorner PS, Arbus GS, Calermajer DS, Baumal R: Focal segmental glomerulosclerosis and progressive renal failure associated with a unilateral kidney. Pediatrics 73: 806-810, 1984
22. Wikstad I, Celsi G, Larsson L, Herin P, Aperia A: Kidney function in adults born with unilateral agenesis or nephrectomised in childhood. Pediatr Nephrol 2: 177-182, 1988
23. Vainio S, Muller U: Inductive tissue interactions, cell signaling, and the control of kidney organogenesis. Cell 90: 975-978, 1997
24. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, La Mantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Coffey SH, Magnuson T: Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science 269: 230-234, 1995
25. Dudley AT, Lyons KM, Robertson EJ: A requirement for BMP-7 during development of the mammalian kidney and eye. Genes Dev 9: 2795-2807, 1995
26. Perantoni AO, Dove LF, Karavanova I: Basic fibroblast growth factor can mediate the early inductive events in renal development. Proc Natl Acad Sci USA 92: 4696-4700, 1995
27. Qiao J, Cohen D, Herzlinger D: FGF-7 uncouples the mitogenic and nephron inducing activities of the ureteric bud [Abstract]. J Am Soc Nephrol 7: 1604A, 1996
28. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M: Renal agenesis and the absence of enteric neurones in mice lacking GDNF. Nature 382: 70-73, 1996
29. Towers PR, Woolf AS, Hardman P: GDNF stimulates ureteric bud outgrowth and enhances survival of ureteric bud cells in vitro. Exp Nephrol 1998, in press
30. Woolf AS, Kolatsi-Joannou M, Hardman P, Andermurcher E, Moorby C, Fine LG, Jat PS, Noble MD, Gherardi E: Roles of hepatocyte growth factor/scatter factor and the met receptor in early development of the metanephros. J Cell Biol 128: 171-184, 1995
31. Rogers SA, Ryan G, Hammerman MR: Insulin-like growth factors I and II are produced in the metanephros and are required for growth and development in vitro. J Cell Biol 113: 1447-1453, 1991
32. Leveen P, Pekny M, Gebre Medhin S, Swolin B, Larsson E, Betsholtz C: Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8: 1875-1887, 1994
33. Rogers SA, Ryan G, Hammerman MR: Metanephric transforming growth factor-α is required for renal organogenesis in vitro. Am J Physiol 262: F533-F539, 1992
34. Loughna S, Hardman P, Landels E, Jussila L, Alitalo K, Woolf AS: A molecular and genetic analysis of renal glomerular capillary development. Angiogenesis 1: 84-101, 1997
35. Stark K, Vainio S, Vassileva G, McMahon AP: Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372: 679-683, 1994
36. Rivtos O, Tuuri T, Eramaa M, Sainio K, Hilden K, Saxen L, Gilbert SF: Activin disrupts epithelial branching morphogenesis in developing glandular organs of the mouse. Mech Der 50: 229-245, 1995
37. Bard JBL, Ross ASA: LIF, the ES-cell inhibition factor, reversibly blocks nephrogenesis in cultured mouse kidney rudiments. Development 113: 193-198, 1991
38. Cale CM, Kline N, Morgan G, Woolf AS: Tumor necrosis factor α inhibits epithelial differentiation and morphogenesis in the mouse metanephric kidney in vitro. Int J Dev Biol 1998, in press
39. Rogers SA, Ryan G, Purchio AF, Hammerman MR: Metanephric transforming growth factor β1 regulates nephrogenesis in vitro. Am J Physiol 264: F996-F1002, 1993
40. Klein G, Langegger M, Timpl R, Ekblom P: Role of laminin A chain in the development of epithelial cell polarity. Cell 55: 331-341, 1988
41. Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanes J, Merlie JP: The renal glomerulus of mice lacking s-laminin/laminin β2: Nephrosis despite molecular compensation by laminin β1. Nat Genet 10: 400-406, 1995
42. Ekblom P: Extracellular and cell adhesion molecules in nephrogenesis. Exp Nephrol 4: 92-96, 1996
43. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepard K, Jones RC, Jaenisch R: Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122: 3537-3547, 1996
44. Muller U, Wang D, Denda S, Meneses JJ, Pedersen RA, Reichardt LF: Integrin α8β1 is critically important for epithelial-mesenchymal interactions during kidney development. Cell 88: 603-613, 1997
45. Hatini V, Huh SO, Herzlinger D, Soares VC, Lai E: Essential role of stromal mesenchyine in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2. Genes Dev 10: 1467-1478, 1996
46. Davis AP, Witte DP, Hsieh-Li HM, Potter SS, Capecchi MR: Absence of radius and ulna in mice lacking hoxa-11 and hoxd-11. Nature 375: 791-795, 1995
47. Shawlot W, Behringer RR: Requirement for Lim1 in head-organizer function. Nature 374: 425-432, 1995
48. Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF: Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev 6: 2235-2247, 1992
49. Torres M, Gomez-Pardo E, Dressler GR, Gruss P: Pax-2 controls multiple steps of urogenital development Development 121: 4057-4065, 1995
50. Rothenpieler UW, Dressier GR: Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development. Development 119: 711-720, 1993
51. Bell DM, Leung KKH, Wheatley SC, Ng LJ, Zhou S, Ling KW, Sham MH, Koopman P, Tam PPL, Cheah KSE: SOX9 directly regulates the type-II collagen gene. Nat Genet 16: 174-178, 1997
52. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT-1 is required for early kidney development. Cell 74: 679-691, 1993
53. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 75: 229-240, 1994
54. Sorenson CM, Rogers SA, Korsmeyer SJ, Hammerman MR: Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. Am J Physiol 268: F73-F81, 1995
55. Mendelsohn C, Lohnes D, Decimo D, Lufkin T, LeMeur M, Chambon P, Mark M: Function of the retinoic acid receptors during development. Development 120: 2749-2771, 1994
56. Morham SG, Lanhcnbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA, Smithies O: Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473-482, 1995
57. Maas R, Elfering S, Glaser T, Jepeal L: Deficient outgrowth of the ureteric bud underlies the renal agenesis phenotype in mice manifesting the limb deformity (ld) mutation. Dev Dyn 199: 214-218, 1994
58. Nguyen HQ, Danilenko DM, Bucay N, De Rose ML, Van GY, Thomason A, Simonet WS: Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. Oncogene 12: 2109-2119, 1997
59. Dressler GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Williams-Simons L, Westphal H: Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362: 65-67, 1993
60. Schuchardt A, D'Agati V, Larsson-Blomberg L, Constnatini F, Pachnis V: Defects in the kidney and nervous system of mice lacking the receptor tyrosine kinase receptor Ret. Nature 367: 380-383, 1994
61. He CJ, Esposito C, Philips C, Zalups RK, Henderson DA, Striker GE, Striker LJ: Dissociation of glomerular hypertrophy, cell proliferation and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest 97: 1242-1249, 1996
62. Brown NA: Chemical teratogens: Hazards, tools and clues. In: Embryos, Genes and Birth Defects, edited by Thorogood P, John Wiley and Sons, 1997, pp 69-88
63. Tse HKW, Woolf AS, Gosling JA, Shum ASW: Embryonic Development of Renal Agenesis in a Mouse Model, British Society for Developmental Biology, Warwick, United Kingdom, Spring 1997
64. Gage JC, Sulik KK: Pathogenesis of ethanol-induced hydronephrosis and hydroureter as demonstrated following in vivo exposure of mouse embryos. Teratology 44: 299-312, 1991
65. Beck AD: The effect of intrauterine urinary obstruction upon the development of the fetal kidney. J Urol 105: 784-789, 1971
66. Attar R, Quinn F, Winyard PJD, Mouriquand PDE, Foxall P, Hanson MA, Woolf AS: Short-term urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal sheep kidneys. Am J Pathol 1998, in press
67. Truong LD, Petrusevska G, Yang G, Gurpinar T, Shappell S: Cell apoptosis and proliferation in experimental chronic obstructive uropathy Kidney Int 50: 200-207, 1996
68. Kaneto H, Morrisey J, Klahr S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ligation Kidney Int 44: 313-321, 1993
69. Chevalier RL: Growth factors and apoptosis in neonatal ureteral obstruction. J Am Soc Nephrol 7: 1098-1105, 1996
70. Steinhardt GF, Liapis H, Philips B, Vogler G, Nag M, Yoon K-W: Insulin-like growth factor improves renal architecture of fetal kidneys with complete ureteral obstruction. J Urol 154: 690-693, 1995
71. Winyard PJD, Nauta J, Lirenman DS, Hardman P, Sams VR, Risdon AR, Woolf AS: Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 49: 135-146, 1996
72. Winyard PJD, Risdon RA, Sams VR, Dressier GR, Woolf AS: The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J Clin Invest 98: 451-459, 1996
73. Winyard PJD, Bao Q, Hughes RC, Woolf AS: Epithelial galectin-3 during human nephrogenesis and childhood cystic diseases. J Am Soc Nephrol 8: 1647-1657, 1997
74. Eccles MR, Wallis LJ, Fidler AE, Spurr NK, Goodfellow PJ, Reeve AE: Expression of the PAX2 gene in human fetal kidney and Wilms' tumor. Cell Growth Differ 3: 279-289, 1992
75. Gnarra JR, Dressier GR: Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res 55: 4092-4098, 1995
76. Maulbecker CC, Gruss P: The oncogenic potential of Pax genes. EMBO J 12: 2361-2367, 1993
77. Stuart ET, Haffner R, Oren M, Gruss P: Loss of p53 function through PAX-mediated transcriptional repression. EMBO J 14: 5638-5645, 1995
78. Barrett DM, Winel RE: Renal cell carcinoma in multicystic dysplastic kidney. Urology 15: 152-154, 1980
79. Cromie WJ, Engelstein MS, Duckett JW: Nodular renal blastema, renal blastema and duplicated collecting systems. J Urol 123: 100-102, 1980
80. Gessler M, Poutska A, Cavenee W, Neve RL, Orkin SH, Bruns GAP: Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778, 1990
81. Kolatsi-Joannou M, Moore R, Winyard PJD, Woolf AS: Expression of hepatocyte growth factor/scatter factor and its receptor, MET, suggests roles in human embryonic organogenesis. Pediatr Res 41: 657-665, 1997
82. Matsell DG, Bennett T, Armstrong RA, Goodyer P, Goodyer C, Han VKM: Insulin-like growth factor (IGF) and IGF binding protein gene expression in multicystic renal dysplasia. J Am Soc Nephrol 8: 85-94, 1997
83. Mesrobian H-GJ, Rushton HG, Bulas D: Unilateral renal agenesis may result from in utero regression of multicystic dysplasia. J Urol 150: 793-794, 1993
84. Granata C, Wang Y, Puri P, Tanaka K, O'Briain DS: Decreased bcl-2 expression in segmental renal dysplasia suggests a role in its morphogenesis. Br J Urol 80: 140-144, 1997
85. Novak RW, Robinson HB: Coincident DiGeorge anomaly and renal agenesis and its relation to maternal diabetes. Am J Med Genet 50: 311-312, 1994
86. Barr M Jr, Cohen MM Jr: ACE inhibitor telepathy and hypocalvaria: The kidney-skull connection. Teratology 44: 485-495, 1991
87. Rothman KJ, Moore LL, Singer MR, Nguyen U-S DT, Mannino S, Milunsky A: Teratogenicity of high vitamin A intake. N Engl J Med 333: 1369-1373, 1995
88. 1Neu mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye and kidney. Proc Natl Acad Sci USA 93: 13870-13875, 1996
89. Keller SA, Jones JM, Boyle A, Barrow LL, Killen PD, Green DG, Kapousta NV, Hitchcock PF, Swank RT, Meisler MH: Kidney and retinal detects (Krd), a transgene-induced mutation with a deletion of mouse chromosome 19 that includes the Pax2 locus. Genomics 23: 309-320, 1994
90. Sanyanusin P, Schimmentl LA, McNoe LA, Ward TA, Pierpoint MEM, Sullivan MJ, Dobyns WB, Eccles MR: Mutations of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 9: 358-364, 1995
91. Sanyanusin P, McNoe LA, Sullivan MJ, Weaver RG, Eccles MR: Mutation of PAX2 in two siblings with renal-coloboma syndrome. Hum Mol Genet 4: 2183-2184, 1995
92. Narahara K, Baker E, Ito S, Yokoyama Y, Yu S, Hewitt D, Sutherland GR, Eccles MR, Richards RI: Localisation of a 10q breakpoint within the PAX2 gene in a patient with a de novo t(10;13) translocation and optic nerve coloboma-renal disease. J Med Genet 34: 213-216, 1997
93. Read AP: Pax genes: Paired feet in three camps. Nat Genet 5: 333-334, 1995
94. Sharma PM, Bowman M, Yu BF, Sukumar S: A rodent model for Wilms' tumors: Embryonal kidney neoplasms induced by N-notroso-N′-methylurea. Proc Natl Acad Sci USA 91: 9931-9935, 1994
95. Fickenscher HR, Chalepakis G, Gruss P: Murine Pax-2 protein is a sequence-specific trans-activator with expression in the genital system. DNA Cell Biol 12: 381-391, 1993
96. Battin J, Lacombe D, Leng JJ: Familial occurrence of hereditary renal adysplasia with Mullerian anomalies. Clin Genet 43: 23-24, 1993
97. Eccles MR, Bailey R, Abbott GD, Sullivan MJ: Unravelling the genetics of vesicoureteric reflux: A common familial disorder. Hum Mol Genet 5: 1425-1429, 1996
98. Feather SA, Woolf AS, Allison J, Barratt TM, Blaydon DC, Malcolm S: Exclusion of key nephrogenesis genes as candidates for familial vesicoureteric reflux [Abstract]. J Am Soc Nephrol 8: 388A, 1997
99. Plachov D, Chowdhury K, Walther C, Simon D, Guenet J-L, Gruss P: Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development 110: 643-651, 1990
100. Bouloux PMG, Munroe PB, Kirk JMW, Besser GM: Sex and smell, an enigma resolved. J Endocrinol 133: 323-326, 1992
101. Hardelin J-P, Levilliers J, Young J, Pholsena M, Legouis R, Kirk J, Bouloux PMJ, Petit C, Schaison G: Xp22.3 deletions in isolated familial Kallmann's syndrome. J Clin Endocrinol Metab 76: 827-831, 1993
102. Schwanzel-Fukuda M, Bick D, Pfaff DW: Leutinizing hormone-releasing hormone-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Mol Brain Res 6: 311-326, 1989
103. Kirk JMW, Grant DB, Besser GM, Shalet S, Smith CS, White M, Edwards O, Bouloux PMJ: Unilateral renal aplasia in X-linked Kallmann's syndrome. Clin Genet 46: 260-262, 1994
104. Duke V, Quinton R, Gordon I, Bouloux P-MG, Woolf AS: Proteinuria, hypertension and chronic renal failure in X-linked Kallmann's syndrome, a defined genetic cause of solitary functioning kidney. Nephrol Dial Transplant 1998, in press
105. Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, Carrozo R, Maestrini E, Pieretti M, Tiallon-Miller P, Brown CJ, Willard HF, Lawrence C, Persico MG, Camerino G, Ballabio A: A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353: 529-536, 1991
106. Soussi-Yanicostas N, Hardelin J-P, Arroyo-Jimenez MM, Ardouin O, Legouis R, Levilliers J, Traincard F, Betton J-M, Cabanie L, Petit C: Initial characterisation of anosmin-1, a putative extracellular matrix protein synthesised by definite neuronal cell populations in the central nervous system. J Cell Sci 109: 1749-1757, 1996
107. Duke V, Winyard PJD, Thorogood PV, Soothill P, Bouloux PMG, Woolf AS: KAL, a gene mutated in Kallmann's syndrome, is expressed in the first trimester of human development. Mol Cell Endocrinol 110: 73-79, 1995
108. Cremer H, Lange R, Chrisroph A, Plomann M, Vopper G, Roes J, Brown R, Baldwin S, Kearmer P, Scheff S, Barthels D, Rajewsky K, Wille W: Inactivation of the N-CAM gene in mice results in reduction of the olfactory bulb and defects in spatial learning. Nature 367: 455-458, 1994
109. Legouis R, Ayer-Le Lievre C, Leibovici M, Lapointe F, Petit C: Expression of the KAL gene in multiple neuronal sites during chicken development. Proc Natl Acad Sci USA 90: 2461-2465, 1993
110. Rugarli EI, Lutz B, Kuranti SC, Wawersik S, Borsani G, Ballabio A, Eichele G: Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting. Nat Genet 4: 19-26, 1993
111. Qian F, Watnick TJ, Onuchic LF, Germino GG: The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1. Cell 87: 979-987, 1996
112. Melnick M, Bixler D, Nance WE, Silk K, Yune H: Familial branchio-oto-renal dysplasia: A new addition to the branchial arch syndromes. Clin Genet 9: 25-34, 1976
113. Konig R, Fuchs S, Dukiet C: Branchio-oto-renal syndrome: Variable expressivity in a five generation pedigree. Eur J Pediatr 153: 446-450, 1994
114. Heimler A, Lieber E: Branchio-oto-renal syndrome: Reduced penetrance and variable expressivity in four generations of a large kindred. Am J Med Genet 25: 15-27, 1986
115. Vincent C, Kalatzis V, Compain S, Levilliers J, Slim R, Graia F, de Lurdes Pereira M, Nivelon A, Croquette M-F, Lacombe D, Vigneron J, Helias J, Broyer M, Callen DF, Haan EA, Weissenbach J, Lacroix B, Bellane-Chantelot C, Le Paslier D, Cohen D, Petit C: A proposed new contiguous gene syndrome on 8q consists of Branchio-oto-renal syndrome, Duane syndrome, a dominant form of hydrocephalus and trapeze aplasia: Implication for the mapping of the BOR gene. Hum Mol Genet 3: 1859-1866, 1994
116. Abdelhak S, Kalatzis V, Heilig R, Compain S, Samson D, Vincent C, Weil D, Cruaud C, Sahly I, Leibovici M, Bitner-Glindzicz M, Francis M, Lacombe D, Vigneron J, Charachon R, Boven K, Bedbeder P, Van Regemorter NV, Weissenbach J, Petit C: A human homologue of the drosophila eyes absent gene underlies Branchio-Oto-Renal syndrome and identifies a novel gene family. Nat Genet 15: 157-164, 1997
117. Bonini NM, Leiserson WM, Benzer S: The eyes absent gene: Genetic control of cell survival and differentiation in the developing drosophila eye. Cell 72: 379-395, 1993
118. Cain DR, Griggs D, Lackey DA, Kagan BM: Familial renal agenesis and total dysplasia. Am J Dis Child 128: 377-380, 1974
119. McPherson E, Carey J, Kramer A, Hall JG, Pauli RM, Schimke RN, Tasin MH: Dominantly inherited renal adysplasia. Am J Med Genet 26: 863-872, 1987
120. Murugasu B, Cole BR, Hawkins EP, Blanton SH, Conley SB, Portman RJ: Familial renal adysplasia. Am J Kidney Dis 18: 495-496, 1991
121. Arfeen S, Rosborough D, Luger AM, Nolph KD: Familial unilateral renal agenesis and focal and segmental glomerulosclerosis. Am J Kidney Dis 21: 663-668, 1993
122. Hinchliffe SA, Chan YF, Jones H, Chan N, Kreczy A, Van VD: Renal hypoplasia and postnatal acquired cortical loss in children with vesicoureteric reflux. Pediatr Neprol 6: 439-444, 1992
123. Risdon RA, Yeung CK, Ransley P: Reflux nephropathy in children submitted to nephrectomy: A clinicopathological study. Clin Nephrol 40: 308-314, 1993
124. Hiraoka M, Hori C, Tsukahara H, Kasuga K, Ishihara Y, Sudo M: Congenitally small kidneys with reflux as a common cause of nephropathy in boys. Kidney Int 52: 811-816, 1997
125. Bailey RR: Vesico-ureteric reflux and reflux nephropathy. Kidney Int 44[Suppl 42]: S80-S85, 1993
126. Noe HN: The long-term results of prospective sibling reflux screening. J Urol 148: 1739-1742, 1992
127. Noe HN, Wyatt RJ, Peeden JN Jr, Rivas ML: The transmission of vesicoureteric reflux from parent to child. J Urol 148: 1869-1871, 1992
128. Feather S, Gordon I, Risdon RA, Woolf AS, Verrier-Jones K: Vesicoureteric reflux: Is it all in the genes? The Lancet 348: 725-728, 1996
129. Nishimura H, Yerkes E, Schulman M, Fogo A, Kon V, Hogan BML, Philips JA III, Brock T, Inagami T, Ichikawa I: Null mutation of the murine angiotensin type 2 receptor gene produces a spectrum of phenotypes resembling human congenital urinary tract anomalies [Abstract]. J Am Soc Nephrol 8: 364A, 1997
130. Yerkes E, Nishimura H, Hohenfellner K, Hunley TE, Yoshida H, Kon V, Philips JA III, Brock JW III, Ichikawa I: Association between the angiotensin type 2 receptor (AT2) genotype and congenital urinary tract anomalies in two independent cohorts [Abstract]. J Am Soc Nephrol 8: 397A, 1997
131. Coles HSR, Burne JF, Raff MC: Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118: 777-784, 1993
132. Woolf AS: Genetic manipulation of the embryonic kidney. Exp Nephrol 5: 152-156, 1997
133. Wilkie AOM, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Malcolm S, Winter RM, Reardon R: Apert syndrome results from localised mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9: 165-172, 1996
134. Cohen MM, Kreiborg S: Visceral abnormalities in the Apert syndrome. Am J Med Genet 45: 758-760, 1993
135. Leppert M, Baird L, Anderson KL, Otterud B, Lupski JR, Lewis RA: Bardet-Biedl syndrome is linked to DNA markers on chromosome 11q and is genetically heterogeneous. Nat Genet 7: 107-111, 1994
136. Hurley RM, Dery P, Nogrady MB, Drummond KN: The renal lesion of the Laurence-Moon-Biedl syndrome. J Pediatr 87: 206-209, 1975
137. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, Keutel J, Hustert E, Wolf U, Tommerup N, Schempp W, Scherer G: Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79: 1111-1120, 1994
138. Houston CS, Opitz JM, Spranger JW, Macpherson RI, Reed MH, Gilbert EF, Herrmann J, Schinzel A: The campomelic syndrome: Review, report of 17 cases, and follow-up on the currently 17-year old boy first reported by Maroteaux. Am J Med Genet 15: 3-28, 1983
139. Coppes MJ, Huff V, Pelletier J: Denys-Drash syndrome: Relating a clinical disorder to alterations in the tumor suppressor gene WT1. J Paediatr 123: 673-678, 1993
140. Jadresic L, Leake J, Gordon I, Dillon MJ, Grant DB, Pritchard J, Risdon RA, Barratt TM: Clinico-pathologic review of 12 children with nephropathy, Wilms' tumour and genital abnormalities (Drash syndrome). J Pediatr 117: 717-725, 1990
141. Budarf M, Collins J, Gong W, Roe B, Wang Z, Bailey LC, Sellinger B, Michaud D, Driscoll D, Emanuel BS: Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene. Nat Genet 10: 269-271, 1995
142. Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsy B, Prieuer M, Aurias A, Raymind FL, Clayton-Smith J, Hatchwell E, McKeown C, Beemer FA, Dallapiccola B, Novelli G, Hurst JA, Ignatius J, Green AJ, Winter RM, Brueton L, Brondum-Nielsen K, Stewart F, Van Essen T, Patton M, Paterson J, Scambler PJ: Spectrum of clinical features associated with interstitial chromosome 22p11 deletions. J Med Genet 34: 798-908, 1997
143. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, Alon N, Wijker M, Parker L, Lightfoot J, Carreau M, Callen DF, Savoia A, Cheng NC, van Berkel CGM, Strunk MHP, Gille JJP, Pals G, Kruyt FAE, Pronk JC, Arwert F, Buchwald M, Joenje H: Expression cloning for the major Fanconi anaemia gene, FAA. Nat Genet 14: 320-323, 1996
144. Paavola P, Salonen R, Weissenbach J, Peltonen L: The locus for Meckel syndrome with multiple congenital abnormalities maps to chromosome 17q21-q24. Nat Genet 11: 213-215, 1995
145. Salonen R: The Meckel syndrome: Clinicopathological findings in 67 patients. Am J Med Genet 18: 671-689, 1984
146. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D: Mutations in CPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 12: 241-247, 1996
147. Hughes-Benzie RM, Hunter AG, Allanson JE, MacKenzie EA: Simpson-Golabi-Behmel syndrome associated with renal dysplasia and embryonal tumors: Localisation of the gene to Xqcen-Xq21. Am J Med Genet 43: 428-435, 1994
148. Wallace M, Zori RT, Alley T, Whidden E, Gray BA: Smith-Lemli-Opitz syndrome in a female with a de novo, balanced translocation involving 7q32: Probable disruption of a SLOS gene. Am J Med Genet 50: 368-374, 1994
149. Tint GS, Salen G, Batta AK, Shefer S, Irons M, Elias MR, Abuelo DN, Johnson VP, Lambert M, Lutz R, Schanen C, Morris CA, Hoganson G, Hughes-Benzie R: Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J Pediatr 127: 82-87, 1995
150. Shimozawa N, Tsukamoto T, Suzuki Y, Orii T, Shirayoshi Y, Mori T, Fujiki Y: A human gene responsible for Zellweger syndrome that affects peroxisome assembly. Science 255: 1132-1134, 1992